SBI² 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Phenotypic screening and assays at SBI² 2026
Nov 2–4, 2026 Boston, MA ~300 attendees Website
19 organizations at SBI² 2026 present work in phenotypic screening and assays: 8 vendors, 7 drug developers and R&D companies and 4 universities and institutes. Between them they bring 25 presentations to the program. Most represented: Genentech (2 on the program), University of Pittsburgh (1 on the program), Araceli Biosciences (1 on the program). As of Nov 2, 2026.
| Organization | SBI² 2026 Attendance |
|---|---|
Genentech South San Francisco, CA | |
Biotechnology company in the Roche group developing medicines for cancer, immune and neurological diseases. | Talk Mon Nov 2 9:00am–12:00pm Processing and Evaluating High-Content Morphological Profiles Practical computing steps that clean noise from image-based cell profiles, and how to check the cleanup keeps real biological differences. Talk Wed Nov 4 8:30am–9:00am Toward Interpretable and Predictive Image-Based Screening Making image-based genetic screens easier to interpret, and testing how well their images predict gene activity. |
University of Pittsburgh Pittsburgh, PA | |
Public research university whose schools of pharmacy and medicine run drug discovery and screening research. | Talk Mon Nov 2 9:00am–12:00pm HCS/HCI/HCA It’s all about the Models How the choice of cell model, from engineered cell lines to tumor spheroids and patient-derived organoids, shapes what an imaging assay can measure. Session Mon Nov 2 1:00pm–3:00pm SBI² Career Panel Career paths and job hunting in biomolecular imaging and informatics, in a difficult job market. Session Mon Nov 2 4:00pm–5:30pm Colloquium: AI Today: The Good, The Bad and the Ugly How pattern recognition, machine learning and language models help and mislead when applied to imaging assays. |
◇Gold Sponsor | |
High-content imaging company whose Endeavor plate readers scan quickly and analyse images as they are acquired, for drug discovery. | Booth Exhibiting at Booth 6 Tue, Nov 38:00am–7:30pmWed, Nov 48:00am–3:30pm Session Mon Nov 2 1:00pm–3:00pm SBI² Career Panel Career paths and job hunting in biomolecular imaging and informatics, in a difficult job market. Session Tue Nov 3 8:30am–8:45am |
Arvinas New Haven, CT | |
Clinical-stage biotech developing medicines that make cells destroy disease-causing proteins. | Session Mon Nov 2 1:00pm–3:00pm SBI² Career Panel Career paths and job hunting in biomolecular imaging and informatics, in a difficult job market. Session Wed Nov 4 1:30pm–4:15pm |
Danish Cancer Institute Copenhagen, Denmark | |
Cancer research institute of the Danish Cancer Society in Copenhagen. | Talk Mon Nov 2 9:00am–12:00pm Optical Pooled Screening: Linking Genetic Perturbations to Cellular Phenotypes How optical pooled screens link gene changes to what cells look like, from library design to reading barcodes inside cells and analyzing the data. Poster Tue Nov 3 5:30pm–7:30pm Defining the genetic determinants of micronucleus formation using optical pooled screening A genome-scale optical screen and a new deep learning model to find which genes control the formation of micronuclei, a marker of chromosomal instability. |
Company pairing human stem-cell-derived liver cells and organoids with AI analysis of cell images for drug discovery and safety. | Talk Mon Nov 2 9:00am–12:00pm A closed-loop phenomics engine for disease-relevant screening: modelling and pharmacological rescue of a fibrotic phenotype with Cell Painting An automated two-microscope screening system that models lung scarring in cells and scores how compounds reverse it and what unwanted effects they cause. Spotlight Tue Nov 3 12:15pm–1:15pm A closed-loop phenomics engine for disease-relevant screening: modelling and pharmacological rescue of a fibrotic phenotype with Cell Painting An automated two-microscope screening system that models lung scarring in cells and scores how compounds reverse it and what unwanted effects they cause. |
University of Copenhagen Copenhagen, Denmark | |
Public research university in Denmark with faculties of science and of health and medical sciences. | Talk Mon Nov 2 9:00am–12:00pm Optical Pooled Screening: Linking Genetic Perturbations to Cellular Phenotypes How optical pooled screens link gene changes to what cells look like, from library design to reading barcodes inside cells and analyzing the data. Poster Tue Nov 3 5:30pm–7:30pm Defining the genetic determinants of micronucleus formation using optical pooled screening A genome-scale optical screen and a new deep learning model to find which genes control the formation of micronuclei, a marker of chromosomal instability. |
Element Biosciences San Diego, CA | ◇Bronze Sponsor |
Sequencing company whose AVITI24 system reads RNA, protein and cell shape from the same individual cells. | Booth Exhibiting at Booth 28 Tue, Nov 38:00am–7:30pmWed, Nov 48:00am–3:30pm Spotlight Wed Nov 4 12:30pm–1:30pm Bridging Imaging and Omics: Multimodal Screening at Single-Cell Resolution A screening method that reads protein, RNA, cell shape and guide RNA from the same cell, then combines them with AI models. |
Molecular Devices San Jose, CA | ◇Gold Sponsor |
Maker of ImageXpress high-content screening systems, microplate readers and image-analysis software for life science research. | Booth Exhibiting at Booth 11 Tue, Nov 38:00am–7:30pmWed, Nov 48:00am–3:30pm Spotlight Tue Nov 3 1:45pm–2:00pm Screen Smarter and faster with the new HCS.ai High-Content Screening System How a new high-content screening system and AI image analysis help acquire and interpret complex imaging data, shown by predicting cell viability. |
Revvity Waltham, MA | ◇Gold Sponsor |
Life science and diagnostics company selling Opera Phenix high-content imagers, Harmony analysis software, PhenoVue reagents and microplates. | Booth Exhibiting at Booth 10 Tue, Nov 38:00am–7:30pmWed, Nov 48:00am–3:30pm Spotlight Tue Nov 3 4:15pm–4:30pm From Plate to Cloud to Universe: A Complete High-Content Imaging Workflow Solution Featuring Opera Phenix OptIQ, Harmony 6, Image Artist 1.6 and PhenoVue Reagents A new high-content imager, analysis software and reagents for 3D cell models, with image analysis available as a hosted cloud service. |
Corteva Agriscience Indianapolis, IN | |
Agricultural science company selling seeds and crop-protection products, with its own investigative toxicology research. | Talk Mon Nov 2 9:00am–12:00pm From Ideation to Application: A Case History of Establishing Phenotypic Profiling Assays for Chemical Hazard Screening Building an imaging assay that profiles chemical hazards without animal testing, and how its results feed into chemical risk assessment. |
Herbert Wertheim UF Scripps Institute Jupiter, FL | |
University of Florida research institute with a large compound library and automated drug discovery screening facilities. | Talk Wed Nov 4 1:30pm–2:00pm Ultra High Content Analysis For Cancer Cell Differentiation Effectors A screen of about 665,000 compounds for drugs that push treatment-surviving breast cancer cells into a harmless fat-cell-like state. |
insitro South San Francisco, CA | |
Drug discovery company using machine learning and large automated cell experiments to find targets for its own pipeline. | Talk Wed Nov 4 3:30pm–4:00pm Pooled screening and tool building for ML-enabled phenotypic rescue in iPSC-derived models of ALS cryptic splicing and TSC mTOR hyperactivation Pooled genetic screens and machine learning in stem-cell-derived models, looking for targets that reverse disease features of ALS and tuberous sclerosis. |
Johnson & Johnson New Brunswick, NJ | |
US healthcare company developing medicines and medical technology across oncology, immunology, neuroscience and other areas. | Session Wed Nov 4 1:30pm–4:15pm |
Merck (MSD) Rahway, NJ | |
US pharmaceutical company, known as MSD outside North America, with medicines and vaccines in oncology, infectious disease and other areas. | Spotlight Wed Nov 4 11:30am–11:45am |
Find buyers in phenotypic screening and assays
Tell us what you sell and we’ll find the people at organizations working on phenotypic screening and assays most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SBI² 2026 by
Not affiliated with or endorsed by the Society of Biomolecular Imaging and Informatics. Submit a correction